Synergistic administration of cyclosporine and fructose diphosph

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 9, 514 25, 514885, 514922, 530317, A61K 3170

Patent

active

057474613

ABSTRACT:
This invention discloses a method of using fructose-1,6-diphosphate (FDP) to help suppress the rejection of internal organs such as kidneys, hearts, etc. At least three major advantages of FDP in conjunction with organ transplants have been identified: (1) FDP can help reduce the unwanted proliferation of certain types of stimulated lymphocytes which would otherwise pose a risk of attacking the non-self cells in the transplanted organ; (2) FDP can also potentiate the effectiveness of cyclosporine as a transplant-protecting immunosuppressant, thereby allowing a reduction in CSA dosages, which in turn can reduce the likelihood and the severity of toxic side effects and other dangers of CSA treatment; (3) FDP can also reduce the amount of damage inflicted on an organ during the removal and storage steps required in organ transplantation.

REFERENCES:
patent: 4448771 (1984-05-01), Cattani et al.
patent: 4546095 (1985-10-01), Markov
patent: 4757052 (1988-07-01), Markov
patent: 4916220 (1990-04-01), Galzigna et al.
patent: 5039655 (1991-08-01), Markov
patent: 5039665 (1991-08-01), Markov
patent: 5196402 (1993-03-01), Braganza et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synergistic administration of cyclosporine and fructose diphosph does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic administration of cyclosporine and fructose diphosph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic administration of cyclosporine and fructose diphosph will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-54613

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.